Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma

Phosphodiesterase 2 (PDE2A) modulates the levels of cAMP/cGMP and was recently found to be involved in mitochondria function regulation, closely related to multiple types of tumor progression. This study aimed to estimate the prognostic significance and biological effects of PDE2A on hepatocellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lin, Zhou, Jinchi, Zhao, Zifeng, Zhu, Yuhan, Xing, Jinliang, An, Jiaze, Guo, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818237/
https://www.ncbi.nlm.nih.gov/pubmed/36611861
http://dx.doi.org/10.3390/cells12010068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818237/
https://www.ncbi.nlm.nih.gov/pubmed/36611861
http://dx.doi.org/10.3390/cells12010068

Ejemplares similares